This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It highlights the confluence of two major cardiovascular epidemics, atrial fibrillation and heartfailure, with preserved ejection fraction. In these conditions, advances in electrophysiology and heartfailure physiology are intertwined and are integrated in this review.
The Resynchronization–Defibrillation for Ambulatory HeartFailure Trial (RAFT; NCT00251251 ) demonstrated a greater 5-year mortality benefit for patients receiving cardiac-resynchronization therapy (CRT) compared to those receiving implantable cardioverter–defibrillators (ICDs). The median follow-up duration for these patients was 7.7
HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more. It’s an honor to have the U.S.’s
It can be associated with reduced quality of life and complications such as heartfailure and stroke. Additional advantages include providing electrophysiology lab personnel with a lead-free working environment and avoiding radiation exposure for both patients and physicians.
Background Sacubitril/valsartan (SacVal) has been shown to improve the prognosis of heartfailure; however, whether SacVal reduces the occurrence of atrial fibrillation (AF) in heartfailure has not yet been elucidated.
Heartfailure (HF) is recognized as an epidemic in the contemporary world, impacting around 1%–2% of the adult population and affecting around 6 million Americans. Among the most serious manifestations associated with HF is arrhythmia due to the electrophysiological changes within the cardiomyocyte.
Heartfailure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) have emerged as major age-related epidemics within cardiology. Indeed, these two conditions are commonly found in the same individual, so much so that AF has been used in proposed diagnostic criteria for HFpEF.
Slow VT below the detection rate of the ICD lead to worsening heartfailure and low stroke volume. Post conversion of VT the patient had low output cardiac failure and became unstable and hypoperfused. Cardiac output (CO) was being maintained by the tachycardia. After atrial rhythm/SR was restored the patient slowly improved.
Background The use of SGLT-2 inhibitors has revolutionized heartfailure therapy. In the presence of pinacidil induced arrhythmogenicity, neither SGLT2 inhibitor had a significant impact on cardiac electrophysiology. Conclusion In this model, empagliflozin and dapagliflozin demonstrated opposite antiarrhythmic properties.
Cardiac electrophysiologic and Cardiovascular involvement has long been important in the surveillance, care, and prognosis of patients with both BMD and DMD, and is the leading cause of mortality in patients with DMD.
ABSTRACT Atrial flutter (AFL), defined as macro-re-entrant atrial tachycardia, is associated with debilitating symptoms, stroke, heartfailure, and increased mortality. Atypical AFL is a heterogenous group of re-entrant atrial tachycardias that most commonly occur in patients with prior heart surgery or catheter ablation.
In heartfailure with reduced ejection fraction and heartfailure with preserved ejection fraction, profound cellular and molecular changes have recently been documented in the failing myocardium.These changes include altered calcium handling and metabolic efficiency of the cardiac myocyte, reactivation of the fetal gene program, changes in the electrophysiological (..)
The PRO portion of the currently featured PRO/CON debate between Dr. Brian Olshansky and Dr. John Mandrola presents a significant conundrum within the fields of electrophysiology and geriatric cardiology.
1,2 People living with AFib face an increased risk of stroke, heartfailure and death, and many rely on cardiac ablation to treat the condition effectively. chief medical officer of Abbott's electrophysiology business. Gian-Battista Chierchia at the University of Brussels in Belgium; and Prof.
BACKGROUND:The relationship between heartfailure (HF) and atrial fibrillation (AF) is clear, with up to half of patients with HF progressing to AF. Circulation, Ahead of Print. The pathophysiological basis of AF in the context of HF is presumed to result from atrial remodeling.
The overexpression of Cav1 reset the influence of vagotomy.ConclusionsWe found that LIPUS had a direct effect on regional antiinflammation and antifibrosis, improved cardiac autonomic function and heartfailure, protected the Cx43 (connexin43) protein, and reduced the risk of malignant arrhythmia during ICM.
Myocardial calcium (Ca2+) signaling plays a crucial role in contractile function and membrane electrophysiology. An abnormal myocardial Ca2+ transient is linked to heartfailure and ventricular arrhythmias.
HeartFailure 2024 Date: May 11-14, 2024 Location: Lisbon, Portugal and online Overview: The HeartFailure Congress stands as the premier global gathering encompassing the full spectrum of heartfailure. Hashtag: #ESCPrev2024 5. Hashtag: #HeartFailure2024 6.
Left bundle branch (LBB) area pacing (LBBAP) has become a cardiac resynchronization therapy (CRT) modality in patients with heartfailure (HF) and LBB block (LBBB). However, the electrophysiological differences between LBBP and LVSP and the methods to differentiate LBBP from LVSP in patients with HF and LBBB need investigations.
This study aimed to assess the electrophysiological characteristics of atrial fibrillation patients with dilated cardiomyopathy and compare the long-term clinical outcomes between patients undergoing catheter ablation and medical therapy.
Brian Olshansky and John Mandrola currently featured presents a conundrum within the fields of electrophysiology and geriatric cardiology. The CON portion of the PRO/CON debate between Drs.
Patients suffering from heart rhythm disorders are now being successfully treated with robotic ablation procedures using this advanced technology, and Hospital Santa Maria della Pietà is the first hospital in Italy to adopt the cutting-edge Genesis Robotic Magnetic Navigation (RMN) system. “As
This potential vascular market for this product family is measured in millions of procedures per year, including cardiac interventions such as structural heart procedures and electrophysiology procedures, peripheral vascular interventions including renal interventions, endovascular aortic repair, and carotid artery interventions.
suffer from heartfailure , and there are approximately 400,000 heart-failure-related deaths in this country each year. Patients with heartfailure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden.
Abstract A vast amount of now well-established clinical and epidemiological data indicates a close, interdependent, and symbiotic association between atrial fibrillation (AF) and heartfailure (HF). Both AF and HF, when co-exist in a patient, have serious treatment and prognostic implications.
He also has New York Heart Association (NYHA) class II heartfailure with reduced ejection fraction and left ventricular ejection fraction (LVEF) 40%. PT is an 82-year-old man who presents with persistent, mildly symptomatic atrial fibrillation (AF) of approximately 4-5 months' duration.
The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. When left untreated, arrhythmias may significantly increase the risk of stroke, heartfailure, and sudden cardiac arrest.
Central illustration: In this study comparing left bundle branch area pacing (LBBAP) versus endocardial resynchronization (Endo-CRT), both strategies were associated with a similar incidence of the composite outcome of heartfailure-related hospitalization and all-cause mortality.
Impact of preceding systolic heartfailure on risk of pacemaker-induced cardiomyopathy Abstract Background Pacemaker-induced cardiomyopathy is a well described phenomenon in patients with preserved ejection fraction at the time of permanent pacemaker implant.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.
ABSTRACT Introduction Atrial fibrillation (AF) can cause or aggravate heartfailure (HF). Catheter ablation (CA) is an effective treatment for AF. This study focused on the feasibility and outcomes of emergent AF ablation performed during hospitalization for acute HF.
ABSTRACT Background Atrial fibrillation (AF) recurrence remains a significant challenge in heartfailure with reduced ejection fraction (HFrEF) patients undergoing cryoballoon ablation (CBA). Secondary endpoints included all-cause mortality and heartfailure (HF)-related hospitalizations. vs. 39.4%, p =0.036).
BACKGROUND:Gene mutations are responsible for a sizeable proportion of cases of heartfailure. Circulation, Ahead of Print. However, the number of patients with any specific mutation is small.
Abstract Introduction Catheter ablation for atrial fibrillation (AF) reduces heartfailure (HF) hospitalization in patients with HF with preserved ejection fraction (HFpEF). However, the long-term outcomes and subclinical HF after nonparoxysmal AF ablation in HFpEF patients have not been fully evaluated.
Diabetes mellitus induces adverse structural, electrophysiological, and autonomic cardiac remodeling which can increase one’s risk of ventricular arrhythmias and SCD. In this narrative review, we describe the contribution of DM to the pathophysiology of SCD beyond its role in atherosclerotic cardiovascular disease and heartfailure.
Abstract Background Heartfailure (HF) with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are associated with high morbidity and mortality. Recently, sinus rhythm (SR) maintenance (SRM) after catheter ablation (CA) of AF (AFCA) in HFpEF has shown to reduce adverse events as compared to medical treatment.
It is also published in Heart Rhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS. 7 Atrial fibrillation has a significant impact on people’s lives.
Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heartfailure, and may prevent the disease from becoming permanent. Patients are often treated with AADs as frontline therapy for heart rhythm maintenance, though some can experience adverse effects and limited efficacy.
Atrial fibrillation (AF) stands as the most prevalent cardiovascular disease, posing significant risks of stroke, heartfailure (HF), and other complications that contribute to morbidity and mortality.
It's a major step towards fulfilling our vision of providing disruptive electrophysiology solutions for patients," said Rebecca Seidel, SVP and President of the Cardiac Ablation Solutions business, which is part of the Cardiovascular Portfolio. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
In addition to these electrophysiological and reversible changes, which occur relatively early during AF, AF has been shown to be also associated with cardiac structural alterations including atrial dilatation and the development of heartfailure (2).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content